SANDOZ INTERNATIONAL

Sandoz International GmbH develops, manufactures, and markets generic pharmaceutical products to customers.
SANDOZ INTERNATIONAL
Industry:
Manufacturing Medical Pharmaceutical
Founded:
1886-01-01
Address:
Holzkirchen, Bayern, Germany
Country:
Germany
Website Url:
http://www.sandoz.com
Total Employee:
10001+
Status:
Active
Contact:
(498)024-4760
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Content Delivery Network Font Awesome Euro IPv6 Google Maps JsDelivr Cloudflare JS
Similar Organizations
Concordia UK
Concordia UK develops, licenses, and markets generic pharmaceutical products.
Guangyuyuan
GuangYuYuan Chinese Herbal Medicine Co., Ltd. develops and manufactures Chinese raw material medicines as well as advertising services.
Jaber Ibn Hayyan Pharmaceutical
Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.
Officina Profumo Farmaceutica di Santa Maria Novella
Santa Maria Novella's Officina Profumo Farmaceutica offers exquisite perfumes and skincare items produced with medical plants.
Current Employees Featured
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-02-11 | GSK - Cephalosporins Antibiotics Business | GSK - Cephalosporins Antibiotics Business acquired by Sandoz International | 500 M USD |
2010-04-19 | Oriel Therapeutics | Oriel Therapeutics acquired by Sandoz International | N/A |
Newest Events participated

Official Site Inspections
http://www.sandoz.com Semrush global rank: 1.14 M Semrush visits lastest month: 27.98 K
- Host name: 151.101.66.191
- IP address: 151.101.66.191
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Sandoz International"
Sandoz - Wikipedia
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geig…See details»
Pioneering access for patients - sandoz-com.cms.sandoz.com
Sandoz is committed to meritocracy, diversity and inclusion, with women representing more than 50% of our global workforce and ... our organization of the future, evolving to become simpler, …See details»
Our people, our culture, our Purpose - annualreport.sandoz.com
A helpful read on a diverse set of opinions in Sandoz, in all geographies, all units and at all levels. Participation is voluntary and responses are strictly confidential. Diversity, equity and inclusion …See details»
Sandoz Org Chart + Executive Team - The Official Board
Feb 4, 2025 The organizational chart of Sandoz displays its 155 main executives including Richard Saynor, Remco Steenbergen and Rebecca GunternSee details»
Regulations of the Board of Sandoz Group AG
3 Regulations of the Board of Directors, the Board Committees and the Executive Committee of Sandoz Group AG ffffff Section 1 Scope of the Regulations, Organization in General Article 1 …See details»
Sandoz 2024 Corporate Governance Report
In 1996, or just 110 years later, Sandoz and Ciba-Geigy merged to create Novartis AG. Sandoz was eventually re-established as the umbrella brand for the generic and biosimilar medicines …See details»
Sandoz - Leadership Team - The Org
The Leadership Team at Sandoz is responsible for steering the strategic direction and operational excellence of the company, ensuring it meets its mission to provide high-quality medicines …See details»
Sandoz IR Presentation
Sandoz operations; 2023-2032 CAGR for Biocomparable, Early Entry Generics and Generics as defined by IQVIA and includes all ATC and NFC forms ... as defined by the World Health …See details»
Our strategy - annualreport.sandoz.com
Sandoz is the global leader in the combined generics and biosimilars market, with one of the broadest portfolios in the industry. In 2024 we provided 902 million patient treatments in more …See details»
Sandoz - The Org
As a division of the Novartis Group, their purpose is to discover new ways to improve and extend people's lives. They contribute to society's ability to support growing healthcare needs by pioneering novel approaches to help people …See details»
Sandoz: Culture - LinkedIn
Future of Sandoz. In October 2023, Sandoz became an independently listed medicines organization! A global market leader in Generics & Biosimilar medicine, Sandoz stepped …See details»
Sandoz - LinkedIn
Sandoz | 978,063 followers on LinkedIn. Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a …See details»
Sandoz CEO slams EU-wide drug price proposal, warns US tariffs …
15 minutes ago The chief executive of generic drugmaker Sandoz said a proposal by the CEOs of Novartis and Sanofi to introduce a Europe-wide list price for new medicines is "deeply …See details»
Sandoz enters new era as standalone global leader in generic and ...
Oct 4, 2023 /CNW/ - Sandoz, the global leader in generic and biosimilar medicines, ... Organization Profile. Sandoz Canada. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET …See details»
Sandoz Mission, Benefits, and Work Culture | Indeed.com
Sandoz has just completed a strong first year as standalone company. We are a global leader in high quality, low cost medicines touching the lives of 700 million patients globally. ... As …See details»
Sandoz - LinkedIn
Sandoz | 977,176 followers on LinkedIn. Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a …See details»
Novartis to Spin Off, List Sandoz Business - WSJ
Novartis AG is planning to spin off its generics-and-biosimilars division Sandoz and list it as a stand-alone company in Switzerland, a move that will enable Novartis to focus on innovative …See details»
Sandoz - PharmaSource
Sandoz is a prominent global leader in off-patent medicines, distinguished by its robust scientific heritage. Operating as a division of Novartis, Sandoz focuses on generic pharmaceuticals and …See details»
Strategic levers to drive shareholder value
Inclusion across our organization; and (iv) building a strong governance framework to foster best practice reporting and conduct, and to ensure transparency, accountability and ethical …See details»
CIENTIFIC HERITAGE - annualreport.sandoz.com
Sandoz today is the leading global provider of off-patent medicines (biosimilars and generics), which account overall for approximately 80% of medicines used worldwide ... Scientific office …See details»